Amphiregulin Is a Vitamin D3 Target Gene in Squamous Cell and Breast Carcinoma

This publication has 21 references indexed in Scilit:

• Amphiregulin Is Coordinately Expressed with Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Interstitial Smooth Muscle of the Human Prostate1
  Endocrinology, 1999
• Coactivator and corepressor complexes in nuclear receptor function
  Current Opinion in Genetics & Development, 1999
• Antiproliferative Effect of 1α,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation
  Endocrinology, 1998
• Differential Effects of EGF and Amphiregulin on Adhesion Molecule Expression and Migration of Colon Carcinoma Cells
  Experimental Cell Research, 1997
• Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers.
  Environmental Health Perspectives, 1997
• Toward Therapeutic Intervention of Cancer by Vitamin D Compounds
  JNCI Journal of the National Cancer Institute, 1997
• Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
  Genes & Development, 1996
• Head and Neck Cancer
  New England Journal of Medicine, 1993
• Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
  New England Journal of Medicine, 1990
• Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7.
  Proceedings of the National Academy of Sciences, 1988